In contrast, NSCLC tumors show higher levels of PD-L1 and PD-L2 promoting immune tolerance, which may be particularly important in the more heterogeneous, immunosuppressive microenvironment of NSCLC [88]. The gene discussed is PDCD1LG2; the disease is non-small cell lung carcinoma.